Tagged with Biotech,

Switzerland Switzerland has been long-established as one of the world’s most innovative countries and boasts a thriving ecosystem of startup biotechs. However, a slow and complex funding cycle means that an increasing number of Swiss biotechs are looking towards the US for funding; a trend that risks destabilising and weakening the…

Taiwan The Chairman & CEO of TaiGen Biotechnology discusses the growth opportunities that the company holds in China, its main target market, and documents how her long-term strategic outlook made the company one of the most successful biotech companies in the region today, holding an unrivalled experience and unique positioning in…

Mexico Joel Osorio, CEO & Founder Alejandro De La Parra, Co-Founder & Chief Operating Officer Alexa Jeppi, Co-Founder, RegenerAge Beauty & Health Ira Pastor, Board Member             The CEO of RegenerAge, Dr. Joel Osorio, explains the transformative power of Bioquantine—a novel biological complex used in regenerative…

Greece Amgen’s mission is clear cut: ‘To Serve Patients’, which is evident in the level of innovation that they bring as the world’s leading biotech company. Complementary to this message is one that GM of Amgen Greece Arvela Matti, strongly wants to reverberate across the Greek pharmaceutical landscape: innovation is an…

Taiwan Hong-Jen Chang, former Deputy Minister of Health and current CEO and Chairman of the YFY Biotech Management Company, a Taiwan-based VC fund which has been playing an instrumental role in the development of Taiwan’s biotech industry, provides insights into his investment approach and documents the key success factors to prioritize…

Taiwan George Lee and Tzu-Ming Pan introduce SunWay Biotech’s groundbreaking red yeast rice extract, ANKASCIN® 568-R, which has been recognized as a New Dietary Ingredient by the US FDA. SunWay Biotech is now bringing this unique product onto the global stage and are considering developing a pharmaceutical product based on the…

Switzerland Well-funded and with a stellar pipeline, TESARO is an up and coming Boston-based oncology biotech ready to launch their two first products in the European market in 2017. Orlando, we understand your background in the biotech industry is with Amgen. After a career with the biggest of the biotechs, what…

Taiwan Chuan-Der Huang, founder, president, and CEO of KriSan Biotech, a recently established Taiwan-based service provider focused on new drug process and analytical R&D for small molecules and peptides from Pre-clinical (IND) to Phase II clinical trial, provides insights into the company’s unique positioning in Taiwan’s new drug development value chain,…

Taiwan Vivian Lee, president and CEO of Linical Taiwan, documents the affiliate’s main milestones since its establishment in 2013, its strategic positioning among the Linical Group as a regional hub, as well as the crucial role Linical Taiwan aims to play in further propelling the impressive growth of Taiwan’s R&D-driven biopharmaceutical…

Mexico José Luis Hernández, general manager at Kedrion Mexico, explains the strategy followed by the affiliate in Mexico to obtain success during the past eight years and showcases the added value of plasma-derivate solutions both for patients and government. What are the primary activities and operations of Kedrion in Mexico? Kedrion…

Switzerland With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the cluster’s key strength lies in the diverse range of capabilities which its members are able to offer as contract services to one another, and of course other interested third…

Taiwan Yita Lee & Muh-Hwan Su of Sinphar Group & SynCore Bio describe the exciting R&D projects of SynCore Bio, the oncology & dry AMD focused innovation-driven company of the group, and the advantages of SynCore Bio’s integration within Sinphar Group. As an introduction to our international readers, could you provide…